CD44 and neoplasm: Similar to the results from primary resistant cells, GAA treatment was also effective in reducing the percentage of CD133+CD44+ cells, mRNA levels of the CSC-specific transcription factors, and the number of tumor spheroids for these acquired-resistant cells (Fig. 5n-q).